Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. is the post-merger entity formed through the business combination of Orchestra BioMed, Inc. and Health Assurance Acquisition Corp, which traded on Nasdaq under the ticker HSAQ. Health Assurance Acquisition Corp was a healthcare-focused blank check company sponsored by Health Assurance Equity Partners, LLC, and completed its IPO in 2020. The de-SPAC transaction closed in early 2023, with the combined company subsequently trading as Orchestra BioMed Holdings under the ticker OBIO. Orchestra BioMed operates in the bioelectronic medicine and cardiovascular medical device sector. The company filed this 8-K current report with the SEC on June 20, 2024, reflecting ongoing public-company reporting obligations following the merger. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time SPAC data on Orchestra BioMed Holdings and hundreds of other transactions.